You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 11, November 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetic Disorders
 •Dementias
 •Neurogenetics
 •Neurology, Other
 •Psychiatry
 •Delirium
 •Alert me on articles by topic

Dementia and Delirium in 4 Patients With Machado-Joseph Disease

Atsushi Ishikawa, MD,PhD; Mitsunori Yamada, MD,PhD; Kunihiko Makino, MD; Izumi Aida, MD; Jiro Idezuka, MD,PhD; Takeshi Ikeuchi, MD,PhD; Yoshiaki Soma, MD,PhD; Hitoshi Takahashi, MD,PhD; Shoji Tsuji, MD,PhD

Arch Neurol. 2002;59:1804-1808.

Background  Machado-Joseph disease (MJD; spinocerebellar ataxia type 3) is a hereditary neurodegenerative disease caused by mutation of the MJD1 gene. Patients with MJD usually present with cerebellar ataxia, external ophthalmoplegia, pyramidal and extrapyramidal signs, and muscle wasting. However, it has been reported that these patients do not demonstrate dementia.

Case Description  We noticed symptoms of dementia and delirium in 4 patients with MJD. The symptoms included abnormal behavior, excitation, an uncooperative attitude, crying, disorientation, slow thought processes, hallucinations, and delusions. These symptoms were observed in patients with a relatively young onset age, and after a long clinical course. In these patients, the CAG repeat length in the MJD1 gene was much longer compared with the mean repeat length found in patients with MJD. On electroencephalographical examination, they showed slow background activity, but computed tomography and magnetic resonance imaging scans showed no cerebrocortical atrophy. Neuropathological findings in 2 patients revealed a normal cortical structure on conventional morphological examination, but at immunohistochemical examination, we found abnormal staining by an antipolyglutamine antibody in the cerebrocortical neuronal nuclei.

Conclusions  Symptoms of dementia and delirium in patients with MJD could occur in the late stages, and they might be caused not by loss of cerebrocortical neurons, but by their dysfunction.


From the Department of Neurology, Nishi-Ojiya National Hospital (Drs Ishikawa, Makino, Aida, and Idezuka), the Department of Pathology, Brain Research Institute, Niigata University (Drs Yamada and Takahashi), the Department of Neurology, Brain Research Institute, Niigata University (Drs Ikeuchi, Soma, and Tsuji), and the Department of Neurology, Niigata National Hospital (Dr Ishikawa), Kashiwazaki, Japan.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease
Alves et al.
Hum Mol Genet 2008;17:2071-2083.
ABSTRACT | FULL TEXT  

Cognitive Impairments in Machado-Joseph Disease
Kawai et al.
Arch Neurol 2004;61:1757-1760.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.